EP Patent

EP2610254A1 — Deuterated benzoquinoline derivatives as inhibitors of vesicular monoamine transporter 2

Assigned to Auspex Pharmaceuticals Inc · Expires 2013-07-03 · 13y expired

What this patent protects

A compound of structural Formula I or a salt thereof, wherein: R 1 -R 27 are independently selected from the group consisting of hydrogen and deuterium; and at least one of R 1 -R 27 is deuterium.

USPTO Abstract

A compound of structural Formula I or a salt thereof, wherein: R 1 -R 27 are independently selected from the group consisting of hydrogen and deuterium; and at least one of R 1 -R 27 is deuterium.

Drugs covered by this patent

Patent Metadata

Patent number
EP2610254A1
Jurisdiction
EP
Classification
—
Expires
2013-07-03
Drug substance claim
No
Drug product claim
No
Assignee
Auspex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.